Cargando…

Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody

MW33 is a fully humanized IgG1κ monoclonal neutralizing antibody, and may be used for the prevention and treatment of coronavirus disease 2019 (COVID-19). We conducted a randomized, double-blind, placebo-controlled, single-dose, dose-escalation Phase 1 study to evaluate the safety, tolerability, pha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Xianmin, Wang, Peipei, Xiong, Yanqing, Wu, Yijun, Lin, Xiaoyan, Lu, Song, Li, Ruowan, Zhao, Bei, Liu, Jing, Zeng, Shaoqing, Zeng, Liyan, Wu, Yan, Lu, Yan, Zhang, Jinchao, Liu, Datao, Wang, Shuhai, Lu, Hongzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382006/ https://www.ncbi.nlm.nih.gov/pubmed/34346827 http://dx.doi.org/10.1080/22221751.2021.1960900

Ejemplares similares

RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates
por: Pan, Xiaoyan, et al.
Publicado: (2021)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Effect of Food on the Pharmacokinetics of Senaparib (IMP4297) in Healthy Chinese Subjects
por: Meng, Xianmin, et al.
Publicado: (2022)

Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
por: Yong, Xiaolan, et al.
Publicado: (2023)

Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants
por: Yi, Chunyan, et al.
Publicado: (2021)

An Algae-Made RBD from SARS-CoV-2 Is Immunogenic in Mice
por: Govea-Alonso, Dania O., et al.
Publicado: (2022)

Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
por: Jiang, Wen, et al.
Publicado: (2021)

Coseismic fault-slip distribution of the 2019 Ridgecrest Mw6.4 and Mw7.1 earthquakes
por: Gao, Yang, et al.
Publicado: (2021)

MW-PPG Sensor: An on-Chip Spectrometer Approach
por: Chang, Cheng-Chun, et al.
Publicado: (2019)

Author Correction: Coseismic fault-slip distribution of the 2019 Ridgecrest Mw6.4 and Mw7.1 earthquakes
por: Gao, Yang, et al.
Publicado: (2021)

Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo
por: Yadav, Naveen, et al.
Publicado: (2021)

α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants
por: Zou, Jintao, et al.
Publicado: (2021)

EuMW special issue
por: Berroth, Manfred, et al.
Publicado: (2014)

Systematic studies on $M_w$
por: Boumediene, D E, et al.
Publicado: (2002)

Multi-MW target station
por: Y.KADI
Publicado: (05/1)

Direct measurement of $m_W$
por: Bigi, M, et al.
Publicado: (1999)

EURISOL-DS Multi-MW Target Neutronic Calculations for the Baseline Configuration of the Multi-MW Target
por: Herrera-Martínez, A, et al.
Publicado: (2006)

Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD
por: Li, Yulei, et al.
Publicado: (2023)

A Polysaccharide-RBD-Fc-Conjugated COVID-19 Vaccine, SCTV01A, Showed High Immunogenicity and Low Toxicity in Animal Models
por: Sun, Chunyun, et al.
Publicado: (2023)

Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
por: Merkuleva, Iuliia A., et al.
Publicado: (2022)

Immunogenicity and safety of a RBD vaccine against SARS-CoV-2 in a murine model
por: Díaz, Andrés, et al.
Publicado: (2022)

Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein
por: Dormeshkin, Dmitri, et al.
Publicado: (2023)

Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
por: Liu, Xiaoqiang, et al.
Publicado: (2022)

Cross-species binding spectrum of ACE2 to SARS-CoV-2 RBD
por: Liao, Xihao, et al.
Publicado: (2022)

Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
por: Liu, Xiaofeng, et al.
Publicado: (2023)

Challenges in MW measurements with ATLAS and CMS
por: Cuth, Jakub
Publicado: (2016)

Letters from M.W. Teucher
por: Teucher, M W
Publicado: (1966)

Prospects for the measurement of $m_W$ at the LHC
por: Boonekamp, M
Publicado: (2015)

A 375 MW Modulator for a 150 MW Klystron at the S-Band Linear Collider Test Facility at DESY
por: Choroba, S, et al.
Publicado: (1996)

Microwave (MW), Ultrasound (US) and Combined Synergic MW-US Strategies for Rapid Functionalization of Pharmaceutical Use Phenols
por: Pawełczyk, Anna, et al.
Publicado: (2018)

SIM imaging resolves endocytosis of SARS-CoV-2 spike RBD in living cells
por: Miao, Lu, et al.
Publicado: (2023)

Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
por: Scaria, Puthupparampil V., et al.
Publicado: (2022)

Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
por: Leal, Lorna, et al.
Publicado: (2023)

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
por: Lu, Qizhong, et al.
Publicado: (2021)

Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study
por: Meng, Xianmin, et al.
Publicado: (2021)

Innovative Waste Management in the Mercury Loop of the EURISOL Multi-MW Converter Target
por: PSI: Jörg Neuhausen, Dorothea Schumann, Rugard Dressler, Susanne Horn, Sabrina Lüthi, Stephan Heinitz, Suresh ChirikiCERN: Thierry Stora, Martin Eller
Publicado: (23/0)

An 18.8–33.9 GHz, 2.26 mW Current-Reuse Injection-Locked Frequency Divider for Radar Sensor Applications
por: Oh, Kwang-Il, et al.
Publicado: (2021)

MW-9, a chalcones derivative bearing heterocyclic moieties, attenuates experimental autoimmune encephalomyelitis via suppressing pathogenic T(H)17 cells
por: Liu, Bei, et al.
Publicado: (2022)

Thin‐Plate Superstructures of the Immunogenic 33‐mer Gliadin Peptide
por: Herrera, Maria Georgina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_22vkf8l1e6v3dqvl0k3e3o8oak